CDSCO Panel Accepts Glenmark's Apremilast Trial Report, Seeks 2-Year PSUR Data Parthika Patel10 Aug 2025 1:00 PM ISTNew Delhi: Glenmark Pharmaceuticals Limited has received approval from the Subject Expert Committee (SEC), functioning under the Central Drugs...
Efinaconazole 10% Proven Safe and Effective for Toenail Fungus in Older Adults: Study Dr Riya Dave3 Aug 2025 8:45 PM ISTA post hoc study published in Mycoses has confirmed that efinaconazole 10% solution is both effective and safe for treating toenail onychomycosis in...
Deucravacitinib Relieves Skin and Joint Symptoms in Psoriasis and Psoriatic Arthritis: Study Dr Riya Dave31 July 2025 8:45 PM ISTResearchers have found in a new research that deucravacitinib significantly improves joint pain and musculoskeletal symptoms in patients with...
The Minds Behind IJDVL: Conversations with Dr. Archana Singal, Dr. Geeti Khullar, Dr. Pooja Arora & Dr. Sunny Duttagupta Dr. Nandita Mohan28 July 2025 7:45 AM ISTIn this video, we shine a spotlight on the recent success of Indian Journal of Dermatology, Venereology and Leprology, where its impact factor has...
Pfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic Dermatitis Parthika Patel4 July 2025 3:00 PM ISTNew Delhi: In a recent regulatory development, the Subject Expert Committee (SEC) under the Dermatology and Allergy division of the Central Drugs...
Methotrexate Microinfusion Shows Promise in Treating Frontal Fibrosing Alopecia, reveals research Dr Riya Dave27 April 2025 8:30 PM ISTAccording to a new study,Methotrexate microinfusion (MMP) is a well-tolerated and effective treatment for frontal fibrosing alopecia (FFA),...
Indian Pharma Market Sees 8.7% Growth in January 2025, But Vaccines, Ophthalmology Struggle Farhat Nasim10 Feb 2025 6:47 PM ISTNew Delhi: The Indian pharmaceutical market (IPM) recorded an 8.7% year-on-year (YoY) growth in January 2025, reaching a monthly value of Rs 19,238...
Stem-cell therapy in Dermatology Challenges and opportunities: Ft. Dr Disha, Dr Abhishek Dr. Nandita Mohan7 Feb 2025 8:30 AM ISTThe remarkable characteristics of stem cells (SCs), particularly their potency, capacity for self-renewal, and clonality, are well known. In recent...
Iberdomide shows Better Outcomes in Cutaneous Manifestations in Systemic Lupus Erythematosus in Multinational Trial Dr.Niharika Harsha B14 Nov 2024 7:30 PM ISTA groundbreaking trial found that Iberdomide, a cereblon modulator, can be added as a background medication in subacute and chronic cutaneous lupus...
individuals with Vitiligo have elevated Cardiovascular Risk, reveals research Dr.Niharika Harsha B29 Oct 2024 8:30 PM ISTA new study found that vitiligo is associated with a significant risk of cardiovascular diseases compared to healthy individuals. The study results...
Twice-Daily Deuruxolitinib Significantly Improves Alopecia Areata Over 24 Weeks: Study Dr Riya Dave11 Oct 2024 8:00 PM ISTResearchers found that twice-daily deuruxolitinib (Leqselvi), at an 8 mg dose, significantly improved hair satisfaction of patients with severe...
Tirbanibulin Proven Safe and Tolerable for Larger Actinic Keratosis Fields, Expanding Treatment Options: Study Deepanshi Bhatnagar18 Aug 2024 9:45 PM ISTUSA: Tirbanibulin ointment, at a 1% concentration, demonstrates good safety and effectiveness for treating actinic keratosis (AK) on areas up...
